BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7540942)

  • 1. Cross-linking of CD30 induces HIV expression in chronically infected T cells.
    Biswas P; Smith CA; Goletti D; Hardy EC; Jackson RW; Fauci AS
    Immunity; 1995 Jun; 2(6):587-96. PubMed ID: 7540942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for CD30 in HIV expression.
    Romagnani S; Annunziato F; Manetti R; Almerigogna F; Biagiotti R; Giudizi MG; Ravina A; Giannò V; Tomasévic L; Maggi E
    Immunol Lett; 1996 Jun; 51(1-2):83-8. PubMed ID: 8811349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
    Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
    Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor.
    Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA
    Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
    Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
    Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95.
    Scheller C; Sopper S; Chen P; Flory E; Koutsilieri E; Racek T; Ludwig S; ter Meulen V; Jassoy C
    J Biol Chem; 2002 May; 277(18):15459-64. PubMed ID: 11854296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.
    Tsitsikov EN; Wright DA; Geha RS
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1390-5. PubMed ID: 9037063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse signaling via CD30 ligand.
    Wiley SR; Goodwin RG; Smith CA
    J Immunol; 1996 Oct; 157(8):3635-9. PubMed ID: 8871664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
    Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
    Muñoz-Fernández MA; Navarro J; Garcia A; Punzón C; Fernández-Cruz E; Fresno M
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):838-45. PubMed ID: 9438495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism.
    Harlin H; Podack E; Boothby M; Alegre ML
    J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
    Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
    Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
    Howard OM; Clouse KA; Smith C; Goodwin RG; Farrar WL
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2335-9. PubMed ID: 7681592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
    J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
    McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
    Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
    Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-kappa B binding proteins.
    Vlach J; Pitha PM
    Virology; 1992 Mar; 187(1):63-72. PubMed ID: 1371030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
    Blazar BR; Levy RB; Mak TW; Panoskaltsis-Mortari A; Muta H; Jones M; Roskos M; Serody JS; Yagita H; Podack ER; Taylor PA
    J Immunol; 2004 Sep; 173(5):2933-41. PubMed ID: 15322151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540.
    Vinante F; Rigo A; Scupoli MT; Pizzolo G
    Blood; 2002 Jan; 99(1):52-60. PubMed ID: 11756152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock induction of HIV production from chronically infected promonocytic and T cell lines.
    Stanley SK; Bressler PB; Poli G; Fauci AS
    J Immunol; 1990 Aug; 145(4):1120-6. PubMed ID: 1696294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.